Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Envista HoldingsMEX:NVST 80 Days Payable is 52.27 as of Mar. 2026, which is 21% below its 10-year median of 66.10. GuruFocus rates MEX:NVST with a GF Score™ of 80/100 and a GF Value™ of MXN332.83. The stock has 4 warning signs investors should review. Among 794 Medical Devices & Instruments companies, Envista Holdings ranks worse than 67.13% on this metric.
The historical rank and industry rank for Envista Holdings's Days Payable or its related term are showing as below:
MEX:NVST'
s Days Payable Range Over the Past 10 Years
Min: 49.13 Med: 66.1 Max: 85.69
Current: 49.13
During the past 10 years, Envista Holdings's highest Days Payable was 85.69. The lowest was 49.13. And the median was 66.10.
MEX:NVST's Days Payable is ranked worse than 67.13% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 67.97
vs MEX:NVST: 49.13
Envista Holdings's Days Payable
declined
from Mar. 2025 (55.47) to Mar. 2026 (52.27).
It may suggest that Envista Holdingsaccelerated paying its suppliers.
Envista Holdings Days Payable Related Terms
Envista Holdings Days Payable Historical Data
* Premium members only.
The historical data trend for Envista Holdings's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:NVST vs MMSI, MMED, STVN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Envista Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Envista Holdings Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Envista Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where Envista Holdings's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Envista Holdings's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Envista Holdings (MEX:NVST) has a Days Payable of 52.27 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Envista Holdings and its competitors. This is 21% below median its historical median of 66.10. Over the past decade, Envista Holdings' Days Payable has ranged from 49.13 to 85.69. According to the industry distribution chart, Envista Holdings ranks #533 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 67.1%.
Is Envista Holdings' Days Payable too high?
Envista Holdings' current Days Payable of 52.27 is 21% below median its 10-year median of 66.10. Over the past 10 years, this metric has ranged from a low of 49.13 to a high of 85.69. The Medical Devices & Instruments industry median Days Payable is 67.97. Envista Holdings' value of 52.27 is 23.1% below this industry median. Based on the distribution chart, Envista Holdings ranks #533 out of 794 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Envista Holdings has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Envista Holdings' Days Payable compare to MMSI and MMED?
According to the Medical Devices & Instruments industry distribution chart, Envista Holdings ranks #533 out of 794 companies for Days Payable. This places Envista Holdings in the lower half of its industry. The industry median Days Payable is 67.97. Envista Holdings' value of 52.27 is 23.1% below this benchmark. Historically, Envista Holdings' own Days Payable has ranged from 49.13 to 85.69 over the past decade. While the company's 10-year median is 66.10 vs. the industry median of 67.97, Envista Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.97, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Envista Holdings's current Days Payable of 52.27 is 23.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Envista Holdings and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Envista Holdings's current Days Payable is 52.27, which is 21% below median its own 10-year median of 66.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Envista Holdings stock overvalued right now?
Envista Holdings (MEX:NVST) has a current Days Payable of 52.27. The stock's GF Value™ is MXN332.83, compared to a current price of MXN370.00 — trading 11.2% above its estimated fair value. The current Days Payable is 52.27, which is 21% below median its 10-year median of 66.10 and 23.1% below the Medical Devices & Instruments industry median of 67.97. Envista Holdings' overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Envista Holdings (MEX:NVST), the current Days Payable is 52.27 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Envista Holdings (MEX:NVST) Overvalued in 2026?
Based on GuruFocus' analysis, Envista Holdings stock appears to be overvalued.
The current stock price of MXN370.00 is trading 11.2% above its estimated GF Value™ of MXN332.83.
Key valuation signals for MEX:NVST:
Days Payable: 52.27 (21% below median its 10-year median of 66.10)
GF Value™: MXN332.83 vs. price of MXN370.00 (11.2% above fair value)
Industry Position: 23.1% below the Medical Devices & Instruments median (#533 of 794)
No single metric tells the full story. See the MEX:NVST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.
80GF Score
Get the complete analysis for MEX:NVST
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:NVST has been successfully added to your 
